127 related articles for article (PubMed ID: 36569014)
1. Kawasaki disease without changes in inflammatory biomarkers: A case report.
Yamashita K; Kanazawa T; Abe Y; Naruto T; Mori M
World J Clin Cases; 2022 Dec; 10(35):13038-13043. PubMed ID: 36569014
[TBL] [Abstract][Full Text] [Related]
2. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
Jin J; Wang J; Lu Y; Fan Z; Huang N; Ma L; Yu H
Indian J Pediatr; 2019 Mar; 86(3):250-255. PubMed ID: 30159809
[TBL] [Abstract][Full Text] [Related]
3. Do cytokines correlate with refractory Kawasaki disease in children?
Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
[TBL] [Abstract][Full Text] [Related]
4. [Glucocorticoid combined with ulinastatin in treatment of Kawasaki disease in children: a non-randomized controlled clinical trial].
Zhao DM; Yin QL; Ji XH; Haiweier M; Meng GY; Cheng QT; Ju LJ
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):780-5. PubMed ID: 26287338
[TBL] [Abstract][Full Text] [Related]
5. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
[TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
[TBL] [Abstract][Full Text] [Related]
7. Incomplete Refractory Kawasaki Disease in an Infant-A Case Report and a Review of the Literature.
Mărginean CO; Meliț LE; Gozar L; Mărginean CD; Mărginean MO
Front Pediatr; 2018; 6():210. PubMed ID: 30101141
[TBL] [Abstract][Full Text] [Related]
8. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
[TBL] [Abstract][Full Text] [Related]
9. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
12. Ulinastatin therapy in kawasaki disease.
Iwashima S; Seguchi M; Matubayashi T; Ohzeki T
Clin Drug Investig; 2007; 27(10):691-6. PubMed ID: 17803344
[TBL] [Abstract][Full Text] [Related]
13. Kawasaki disease in Sicily: clinical description and markers of disease severity.
Maggio MC; Corsello G; Prinzi E; Cimaz R
Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
[TBL] [Abstract][Full Text] [Related]
14. Kawasaki disease with a concomitant primary Epstein - Barr virus infection.
Rosenfeld N; Tasher D; Ovadia A; Abiri S; Dalal I
Pediatr Rheumatol Online J; 2020 Aug; 18(1):65. PubMed ID: 32787862
[TBL] [Abstract][Full Text] [Related]
15. High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki Disease.
Lee KY; Lee HS; Hong JH; Han JW; Lee JS; Whang KT
J Trop Pediatr; 2005 Apr; 51(2):98-101. PubMed ID: 15677370
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
Lei WT; Chang LS; Zeng BY; Tu YK; Uehara R; Matsuoka YJ; Su KP; Lee PC; Cavalcante JL; Stubbs B; Lin PY; Wu YC; Hsu CW; Chen TY; Chen YW; Yeh PY; Sun CK; Tseng PT; Kao YH
EBioMedicine; 2022 Apr; 78():103946. PubMed ID: 35306339
[TBL] [Abstract][Full Text] [Related]
17. [A retrospective analysis of 602 Kawasaki disease cases with electronic data capture system].
Xie L; Zhou C; Wang R; Xiao T; Shen J; Huang M
Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):34-9. PubMed ID: 25748402
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin in Kawasaki disease: upregulation by acute inflammation in patients having resistance to intravenous immunoglobulin therapy.
Ishikawa T; Wada Y; Namba H; Kawai T
Clin Rheumatol; 2021 Dec; 40(12):5019-5024. PubMed ID: 34148165
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
20. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
